Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PIK-75 (hydrochloride)

PIK-75 hydrochloride is a reversible DNA-PK and p110α-selective inhibitor, which inhibits DNA-PK, p110α and p110γ with IC50s of 2, 5.8 and 76 nM, respectively. PIK-75 hydrochloride inhibits p110α >200-fold more potently than p110β (IC50=1.3 μM) [1][2]. PIK-75 hydrochloride induces apoptosis[3].

Product Specifications

CAS Number

[372196-77-5]

UNSPSC

12352005

Hazard Statement

H302

Target

Apoptosis; DNA-PK; PI3K

Type

Reference compound

Related Pathways

Apoptosis; Cell Cycle/DNA Damage; PI3K/Akt/mTOR

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/pik-75.html

Purity

99.66

Solubility

DMSO : 11 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

BrC(C=C1)=CN2C1=NC=C2/C=N/N(S(=O)(C3=C(C=CC([N+]([O-])=O)=C3)C)=O)C.[H]Cl

Molecular Formula

C16H15BrClN5O4S

Molecular Weight

488.74

Precautions

H302

References & Citations

[1]Knight ZA, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006 May 19;125 (4) :733-47.|[2]Chaussade C, et al. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J. 2007 Jun 15;404 (3) :449-58.|[3]Duong HQ, et al. Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine. Int J Oncol. 2014 Mar;44 (3) :959-69.|[4]Hayakawa M, Kawaguchi K, Kaizawa H, et al. Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem. 2007;15 (17) :5837-5844.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

PI3KC2α; PI3KC2β; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ; Vps34

Citation 01

Clin Cancer Res. 2020 Apr 15;26 (8) :2011-2021. |Res Sq. 2023 Apr 6:rs.3.rs-2688694.|Adv Sci (Weinh) . 2024 Jun 3:e2400023.|Cell Rep. 2025 Feb 5;44 (2) :115246.|Molecules. 2020 Apr 23;25 (8) :1980.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

DLX5 (Distal-less Homeobox 5) (HRP)
245407-HRP 100 µL

DLX5 (Distal-less Homeobox 5) (HRP)

Ask
View Details
MHC Class 1, H-2Dd, H-2Kv, H-2k/q/s (MHC Class I, H-2Dd, H-2Kv, H-2k/q/s) (Biotin)
MBS6249146-01 0.1 mL

MHC Class 1, H-2Dd, H-2Kv, H-2k/q/s (MHC Class I, H-2Dd, H-2Kv, H-2k/q/s) (Biotin)

Ask
View Details
MHC Class 1, H-2Dd, H-2Kv, H-2k/q/s (MHC Class I, H-2Dd, H-2Kv, H-2k/q/s) (Biotin)
MBS6249146-02 5x 0.1 mL

MHC Class 1, H-2Dd, H-2Kv, H-2k/q/s (MHC Class I, H-2Dd, H-2Kv, H-2k/q/s) (Biotin)

Ask
View Details
Human EPHX1 qPCR Primer Pair
QH13829S 200 Tests

Human EPHX1 qPCR Primer Pair

Ask
View Details
Nylander 's Reagent (Test Reagent for Glucose in urine)
869900 50 mL

Nylander 's Reagent (Test Reagent for Glucose in urine)

Ask
View Details
Recombinant Human V-Set Domain Containing T Cell Activation Inhibitor 1
MBS145551-01 0.005 mg

Recombinant Human V-Set Domain Containing T Cell Activation Inhibitor 1

Ask
View Details